Access to anti-retroviral drugs, female in World
World: Access to anti-retroviral drugs, female was 83.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in World, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
World recorded 83.0% for access to anti-retroviral drugs, female in 2024. That is the highest value across all 25 years on record.
Compared with earlier readings it is up 2.5% on the previous year and up 76.6% over ten years.
Over the whole period, access to anti-retroviral drugs, female in World peaked at 83.0% in 2024 and was at its lowest, 1.0%, in 2000.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in World, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 1.0% | — |
| 2001 | 1.0% | +0.0% |
| 2002 | 1.0% | +0.0% |
| 2003 | 2.0% | +100.0% |
| 2004 | 3.0% | +50.0% |
| 2005 | 5.0% | +66.7% |
| 2006 | 7.0% | +40.0% |
| 2007 | 11.0% | +57.1% |
| 2008 | 15.0% | +36.4% |
| 2009 | 19.0% | +26.7% |
| 2010 | 25.0% | +31.6% |
| 2011 | 31.0% | +24.0% |
| 2012 | 37.0% | +19.4% |
| 2013 | 42.0% | +13.5% |
| 2014 | 47.0% | +11.9% |
| 2015 | 52.0% | +10.6% |
| 2016 | 58.0% | +11.5% |
| 2017 | 64.0% | +10.3% |
| 2018 | 67.0% | +4.7% |
| 2019 | 70.0% | +4.5% |
| 2020 | 73.0% | +4.3% |
| 2021 | 76.0% | +4.1% |
| 2022 | 78.0% | +2.6% |
| 2023 | 81.0% | +3.8% |
| 2024 | 83.0% | +2.5% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 6.5% | 1.0% | 19.0% | 10 |
| 2010s | 49.3% | 25.0% | 70.0% | 10 |
| 2020s | 78.2% | 73.0% | 83.0% | 5 |
Countries ranked near World
More gender data for World
- Child population (UN estimates and projections) 1.96 million (2030)
- Child population (UN estimates and projections) (0-14), annual growth -0.4902 % change on previous year (2030)
- Population 6.61 million (2030)
- Working-age population (UN estimates and projections) 6.61 million (2030)
- Population (UN estimates and projections), annual growth rate 1.16 % change on previous year (2030)
- Inactivity rate (ILO modelled estimates) 39.48 (2027)
- Prevalence of obesity, female 15.1% (2016)
- Prevalence of obesity, male 11.1% (2016)
- Child population (UN estimates and projections) (0-14), per capita 0.0002 units per person (2025)
- Population (UN estimates and projections), per capita 0.0008 units per person (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in World?
- Access to anti-retroviral drugs, female in World was 83.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in World?
- The highest recorded value was 83.0% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in World?
- The lowest recorded value was 1.0% in 2000.
- How does World rank for access to anti-retroviral drugs, female?
- World ranks 15th out of 19 groups with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in World?
- Over the last ten years it is up 76.6%. The long-run trend across the full record is volatile.
- Where does this World data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.